BioCentury
ARTICLE | Clinical News

AeroLEF: Phase IIa data

October 11, 2004 7:00 AM UTC

In a Canadian Phase IIa trial in 24 patients, 95% of patients safely self-titrated AeroLEF and achieved analgesia. ...